1-naphthylisothiocyanate has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera-Chimal, J; Bucio-Ortiz, L; Gomez-Quiroz, LE; Gutiérrez-Ruiz, MC; Lazzarini-Lechuga, R; López-Ramirez, J; Masso, F; Miranda-Labra, RU; Roma, MG; Salas-Silva, S; Simoni-Nieves, A; Souza, V | 1 |
| Braden, TK; Paterson, DA; Reily, MD; Robertson, DG; Sigler, RE; Wells, DF | 1 |
2 other study(ies) available for 1-naphthylisothiocyanate and Kidney Diseases
| Article | Year |
|---|---|
Hepatocyte growth factor reverses cholemic nephropathy associated with α-naphthylisothiocyanate-induced cholestasis in mice.
Topics: 1-Naphthylisothiocyanate; Animals; Antioxidants; Bile Acids and Salts; Bile Ducts; Cholestasis; Disease Models, Animal; Hepatocyte Growth Factor; Kidney; Kidney Diseases; Liver; Male; Mice; Oxidative Stress; Reactive Oxygen Species | 2022 |
Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants.
Topics: 1-Naphthylisothiocyanate; Aminophenols; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Ethylamines; Furosemide; Kidney; Kidney Diseases; Liver; Magnetic Resonance Spectroscopy; Male; Pattern Recognition, Automated; Quantitative Structure-Activity Relationship; Rats; Rats, Wistar; Toxicity Tests; Toxicity Tests, Acute | 2000 |